World Contraception Day 2016: Better Quality of Life for Indonesian Families by increasing use of contraception and improving reproductive health of women
- Bayer and partners commemorate World Contraception Day 2016 in Poncokusumo, Malang Regency with attendance by the Coordinating Minister for Human Development and Cultural Affairs, Head of the National Population and Family Planning (BKKBN), Governor of East Java and Regent of Malang.
- Bayer supports 5th Nawa Cita: “Improve Quality of Life” by helping Indonesians to achieve a better quality of life by means of family planning, use of contraception and improving the reproductive health of Indonesian women.
- Bayer continues to support national Blue Circle FP program by continuing the close to 30-year collaboration with BKKBN.
- Bayer sponsored Family Planning Ambassadors are trained and will spend the year educating the public in the greater Malang area on reproductive health and contraception.
Malang, 27 September 2017
PT Bayer Indonesia and its partners are commemorating World Contraception Day 2016 in Poncokusumo, Malang Regency, East Java. The Bayer supported World Contraception Day (WCD) was first launched globally in 2007 with annual commemoration around the world, ever since. The WCD highlights a grand vision where every pregnancy is wanted and that each country or region adapts it to local relevance to achieve the same goal. This year WCD in Indonesia is supported by PT Bayer Indonesia, the Coordinating Ministry for Human Development and Cultural Affairs of Indonesia (Menko PMK), the National Population and Family Planning Board (BKKBN) and the Regency of Malang, and the event includes family planning services families in the surrounding community along with the launch of the Family Planning Ambassador program in Malang with support from Bayer.
Bayer supports the Indonesian government especially for realizing the national program on population, family planning and family development (KKBPK), a priority program for the government. Bayer’s partnership with BKKBN goes back to 1987 when the Blue Circle Family Planning program was first launched. Bayer is a strong supporter for the government program that drives for the public to be independent users of contraception as part of family planning. This year, Bayer again actively supports the Blue Circle Family Planning endeavor that focuses on educating the public by launching the Family Planning Ambassador Program. This program involves 20 top midwives from the greater area of Malang, East Java who are trained and tasked for an entire year to focus on educating the public so as to increase the use of contraception and to ensure that women are aware and are taking care of their reproductive health, all as part of the family planning program. A similar program was also launched last year in Sragen, Central Java.
Ashraf Al-Ouf, President Director of PT Bayer Indonesia: “Bayer has been a partner of BKKBN for close to thirty years for the Blue Circle Family Planning Program. As the Life Science company in Indonesia and as the market leader for Oral Contraceptive, Bayer fully supports the national development agenda of Nawa cita number 5 – “Improve Quality of Life” – and continue to contribute in helping Indonesians achieve a better quality of life. PT Bayer Indonesia closely collaborate with the government to educate the public so that they in turn can make the right, informed decisions for using contraception as part of their family planning and the overall effort in achieving a better quality of life. To realize this, we support the training of 20 midwives and their Family Planning Ambassador program that cover the greater area of Malang (Malang city, Malang Regent and Batu Regent), just as we did with 20 midwives for Sragen, Central Java, last year. These Family Planning Ambassadors will focus for an entire year to educate the public on the importance of reproductive health and the use of contraception as part of family planning.”
During this year’s WCD commemoration, BKKBN also highlights the importance on public education for family planning. The use of contraceptives to plan for pregnancy and as part of the overall family planning is critical towards a healthier and more prosperous family. As such, BKKBN calls for all stakeholders to support the national program on population, family planning and family development (KKBPK), so that the mental revolution can continue.
The collaboration between Bayer and BKKBN for public education on reproductive health is an ongoing effort. Data from Health and Demographic Survey of Indonesia (SDKI) ror 2007 and 2012 show that a stagnant development in family planning. Several key indicators such as the national birth rate remains at 2.6 with the use of contraceptive hovering at 57% and unmet need remains high at 8.5.
About Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.
Head of Communication PT Bayer Indonesia
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.